Residency · Abington, PA
Sponsored by Abington Memorial Hospital
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
The New England journal of medicine · 2023 · 703 citations · Mark Shahin
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
The New England journal of medicine · 2023 · 633 citations · Mark Shahin
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.
Gynecologic oncology · 2023 · 160 citations · Gretchen Glaser
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 89 citations · Mitchell Edelson
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
Cell · 2021 · 515 citations · Sarah Mokma
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 148 citations · Mark Shahin
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy.
Fertility and sterility · 2021 · 226 citations · Arthur Castelbaum
Identification of bacteria-derived HLA-bound peptides in melanoma.
Nature · 2021 · 364 citations · Sarah Mokma